Contact Us For Veterinairians

Welcome Veterinarians

Since 2007, thousands of dogs1 have been treated with an innovative therapeutic vaccine from Merial as an adjunct therapy for canine oral melanoma (COM). The vaccine was available under a conditional license for use following surgical removal of primary oral melanoma tumors.

Merial is pleased to announce that this targeted DNA vaccine – the first targeted DNA vaccine that aids in extending survival time in dogs treated for COM – has received full licensure from the USDA as ONCEPT® Canine Melanoma Vaccine, DNA.* ONCEPT is now available to specialists practicing veterinary oncology.

If you are interested in receiving the latest news and data concerning ONCEPT Canine Melanoma Vaccine, DNA, please contact Merial Technical Solutions at 1-888-MERIAL-1, Option 3.